| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9197432 | Neurocirugía | 2005 | 11 Pages |
Abstract
This paper has been divided in three parts: in the first one, we summarize the pathophysiological mecha-nisms related to SHI, targeted by the neuroprotective agents. In the second part we review the main clinical triáis carried out for SHI to date, and in the third one, we analyze the possible reasons that explain why these agents have failed to show efficacy.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
G.R. Boto, P.A. Gómez, R.D. Lobato, J. De la Cruz,